The ENTR ETF: Once Incurable Maladies Now Within Reach

By: ETFdb
The healthcare sector has been solid in 2020, but the truly impressive gains are coming by way of the companies disrupting the industry. Investors looking to access high-flying names such as CRISPR Therapeutics (NASDAQ: CRSP) and Twist Bioscience (NASDAQ: TWST) should consider innovative strategies such as the Entrepreneur 30 Fund ( ENTR ).
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.